Recombinant RNasin(R) RNase Inhibitor, 2,500u
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0454099
- Awardee
- PROMEGA CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $138.60
About this award
The University of Virginia awarded a contract to Promega Corporation on July 3, 2026, for the procurement of laboratory reagents. The prime contractor is supplying Recombinant RNasin (Ribonuclease Inhibitor) in a 2,500 unit quantity, with delivery directed to Jaeda Coutinho-Budd at the University of Virginia. The contract encompasses a single line item purchase with a unit price of $138.60 per unit.
The cumulative contract value is $138.00, representing a minimal procurement transaction. No specific performance period or county designation is specified in the award documentation. This contract award reflects a routine purchase of biological research materials by the Virginia institution, with Promega Corporation serving as the sole supplier for this particular reagent requirement.
Line items
| Item | Total |
|---|---|
| Recombinant RNasin(R) RNase Inhibitor, 2,500u | $138.60 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0454099?
Contract A207_PO-0454099 was awarded to PROMEGA CORPORATION by University of Virginia on July 3, 2026.
How much is contract A207_PO-0454099 worth?
Its cumulative value is $138.60.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award